by John Conrad | Jul 22, 2024 | iBIO News
The biotech sector has experienced a remarkable turnaround in 2024, with the SPDR S&P Biotech ETF (XBI) climbing 22% from its April low and posting an 11% year-to-date gain. This recovery reflects renewed optimism in an industry that has overcome significant...
